ERIN PETERS: Open Payments
NPI 1316513450 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$411 in 17 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $39 · 2025 $411
Food & beverage: $411
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $92 |
| Vanda Pharmaceuticals Inc. | 2 | $57 |
| MERZ NORTH AMERICA, INC. | 2 | $53 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $45 |
| Ipsen Biopharmaceuticals, Inc | 1 | $34 |
| UCB, Inc. | 1 | $30 |
| Amneal Pharmaceuticals LLC | 1 | $28 |
| Eisai Inc. | 1 | $21 |
| CSL Behring | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
Products named: QULIPTA, PONVORY, FIRDAPSE, Dysport, Fintepla, BOTOX, CREXONT, Xeomin.
Industry payments across CT — which companies pay providers there.
